Hepatitis B and C viruses in the development of hepatocellular carcinoma - PubMed (original) (raw)

Review

Hepatitis B and C viruses in the development of hepatocellular carcinoma

M W Yu et al. Crit Rev Oncol Hematol. 1994 Oct.

No abstract available

PubMed Disclaimer

Similar articles

• The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
  Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M. Matsuzaki Y, et al. J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. J Exp Clin Cancer Res. 1999. PMID: 10606185
• Hepatitis B virus. The major etiology of hepatocellular carcinoma.
  Beasley RP. Beasley RP. Cancer. 1988 May 15;61(10):1942-56. doi: 10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j. Cancer. 1988. PMID: 2834034 Review. No abstract available.
• Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
  Idilman R, De Maria N, Colantoni A, Van Thiel DH. Idilman R, et al. J Viral Hepat. 1998 Sep;5(5):285-99. doi: 10.1046/j.1365-2893.1998.00116.x. J Viral Hepat. 1998. PMID: 9795912 Review.
• Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
  Chiesa R, Donato F, Tagger A, Favret M, Ribero ML, Nardi G, Gelatti U, Bucella E, Tomasi E, Portolani N, Bonetti M, Bettini L, Pelizzari G, Salmi A, Savio A, Garatti M, Callea F. Chiesa R, et al. Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):213-6. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10698484
• High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
  Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, Okamoto H. Shrestha SM, et al. J Gastroenterol Hepatol. 2007 Nov;22(11):1921-8. doi: 10.1111/j.1440-1746.2006.04611.x. J Gastroenterol Hepatol. 2007. PMID: 17914971

Cited by

• Identification and validation of candidate clinical signatures of apolipoprotein L isoforms in hepatocellular carcinoma.
  Wang XK, Guo YX, Wang M, Zhang XD, Liu ZY, Wang MS, Luo K, Huang S, Li RF. Wang XK, et al. Sci Rep. 2023 Nov 28;13(1):20969. doi: 10.1038/s41598-023-48366-0. Sci Rep. 2023. PMID: 38017264 Free PMC article.
• Synchronous/Metachronous Multiple Primary Malignancies: Review of Associated Risk Factors.
  Pan SY, Huang CP, Chen WC. Pan SY, et al. Diagnostics (Basel). 2022 Aug 11;12(8):1940. doi: 10.3390/diagnostics12081940. Diagnostics (Basel). 2022. PMID: 36010291 Free PMC article. Review.
• H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection.
  Shen YC, Hsu HC, Lin TM, Chang YS, Hu LF, Chen LF, Lin SH, Kuo PI, Chen WS, Lin YC, Chen JH, Liang YC, Chang CC. Shen YC, et al. J Clin Oncol. 2022 Apr 10;40(11):1206-1219. doi: 10.1200/JCO.21.01802. Epub 2022 Jan 19. J Clin Oncol. 2022. PMID: 35044851 Free PMC article.
• Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance.
  Wang SH, Yeh SH, Chen PJ. Wang SH, et al. Cancers (Basel). 2021 May 18;13(10):2454. doi: 10.3390/cancers13102454. Cancers (Basel). 2021. PMID: 34070067 Free PMC article. Review.
• Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients.
  Kim SH, Kwon WA, Joung JY. Kim SH, et al. World J Mens Health. 2021 Apr;39(2):358-365. doi: 10.5534/wjmh.190135. Epub 2020 Feb 5. World J Mens Health. 2021. PMID: 32202082 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information